Acer Therapeutics Inc expected to post a loss of 25 cents a share - Earnings Preview

Acer Therapeutics

12/08/2023 03:06

* Acer Therapeutics Inc  ACER.OQ   ACER.O  is expected
to show a
rise in quarterly revenue when it reports  results on August 14
(estimated). 
    * The Newton Massachusetts-based  company is expected to
report
revenue of $300 thousand, according to the mean estimate from 2
analysts, based on Refinitiv data.  
    * ​Refinitiv's mean analyst estimate for Acer Therapeutics
Inc is
for a loss of 25 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Acer
Therapeutics
Inc is $11​, above​ its last closing price of $0.72. ​​​

This summary was machine generated August 12 at 02:06 GMT.  All
figures in US dollars  unless otherwise stated